Obesity as a medical and public health problem;Deblijina, medicinski i javnozdravstveni problem

Lijecnicki Vjesnik

Volumn 131, Issue 9-10, 2009, Pages 279-285

  Jelčić, Jozo ^a,b   Koršić, Mirko ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b KBC Zagreb   (Croatia)

Author keywords

Adipose tissue Physiopathology; Obesity Physiopathology, complications, therapy; Public health; Weight loss

Indexed keywords

HUMAN; OBESITY; PATHOPHYSIOLOGY; REVIEW;

HUMANS; OBESITY;

EID: 73449137614     PISSN: 00243477     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (89)

1. WHO, Fact sheet N°311. 2006 September.
2. James WPT, Rigby N, Leach R. The obesity epidemic, metabolic syndrome and future prevention strategies. Eur J Cardiovasc Prev Rehabil 2004;11:3-8.
3. American Heart Association. Heart Disease and Stroke Statistics - 2008 Update. Dallas: American Heart Association; 2008.
4. Heim I, Leontić K, Gostović MJ. Obesity and overweight in Croatia. Acta Med Croat 2007;61(3):267-73.
5. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel HI). Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP). JAMA 2001;285:2486-97.
6. The IDF consensus Worldwide definition od the metabolic syndrome. Internat Diabet Fed Vol 2005;2005.
7. Alberti KG, Zimmet P, Shaw J and for the IDF Epidemiology Task Force Consensus Group. The metabolic syndrome - a new worldwide definition. Lancet 2005;366(9491): 1059-62.
8. Rimm EB, Stampfer MJ, Giovannucci E i sur. Body size and fat distribution as predictors of coronary heart disease among middle-aged and older US men. Am J Epidemiol 1995;141:1117-27.
9. Rexrode KM, Carey VJ, Hennekens ChM i sur. Women abdominal adiposity and coronary heart disease in women. JAMA 1998;280(21): 1843-8.
10. Vohl MC, Sladek R, Robitaille J i sur. A survey of genes differentially expressed in subcutaneous and visceral adipose tissue in men. Obes Res 2004; 12(8): 1217-22.
11. Linder K, Arner P, Flores-Morales A, Tollet-Egnell P, Norstedt G. Differentially expressed genes in visceral or subcutaneous adipose tissue of obese men and women. J Lipid Res 2004;45(l):148-54.
12. Arner P. Hunting for human obesity genes? Look in the adipose tissue! Int J Obes Relat Metab Disord 2000;24(Suppl. 4):57-62.
13. Ambrosini G, NathAK, Sierra-Honigmann MR, Flores-Riveros J. Transcriptional activation of the human leptin gene in response to hypoxia. Involvement of hypoxia-inducible factor 1. J Biol Chem 2002;277: 34601-09.
14. Ozean U, Cao Q, Yilmaz E i sur. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 2004;306:457-61.
15. Kurata A, Nishizawa H, Kihara S i sur. Blockade of angiotensin II type-1 receptor reduces oxidative stress in adipose tissue and ameliorates adipocytokine dysregulation. Kidney Int 2006;70( 10): 1717-24.
16. Hosogai N, Fukuhara A, Oshima K i sur. Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes 2007;56(4):901-11.
17. Okura T, Koda M, Ando F, Niino N, Ohta S, Shimokata H. Association of polymorphisms in the estrogen receptor alpha gene with body fat distribution. Int J Obes Relat Metab Disord 2003;27(9): 1020-7.
18. Dieudonne MN, Pecquery R, BoumedieneA, Leneveu MC, Giudicelli Y. Androgen receptors in human preadipocytes and adipocytes: regional specificities and regulation by sex steroids. Am J Physiol 1998;274(6 Pt l):C1645-52.
19. Van Rossum EF and Lamberts SW. Polymorphisms in the glucocorticoid receptor gene and their associations with metabolic parameters and body composition. Recent Prog Horm Res 2004;59:333-57.
20. Li LL, Ma XL, Ran JXi sur. Genetic polymorphism of peroxisome pro- liferator-activated receptor-gamma 2 Pro 12Ala on ethnic susceptibility to diabetes in Uygur, Kazak and Han subjects. Clin Exp Pharmacol Physiol 2008;35(2): 187-91.
21. González-Sánchez JL, Zabena C i sur. Variant rs9939609 in the FTO gene is associated with obesity in an adult population from Spain. Clin Endocrinol 2008 Jun 27.
22. González-Sánchez JL, Zabena C, Martínez-Larrad MT, Martinez-Ca- latrava MJ, Pérez-Barba M, Serrano-Ríos M. Association of ENPP1 (PC-1) K121Q polymorphism with obesity-related parameters in subjects with metabolic syndrome. Clin Endocrinol 2008;68(5):724-9.
23. Ting S, Liu XM, Sun YM, Pan SH. Genetic polymorphism c.l438AG of the 5-HT(2A) receptor is associated with abdominal obesity in Chinese Northern Han population. Mol Biol Rep 2009;36(l):91-5.
24. Peeters A, Beckers S, Mertens I, Van Hul W, Van Gaal L. The G1422A variant of the cannabinoid receptor gene (CNR1) is associated with abdominal adiposity in obese men. Endocrine 2007;31(2): 138-41.
25. Warensjö E, Ingelsson E, Lundmark P i sur. Polymorphisms in the SCD1 gene: associations with body fat distribution and insulin sensitivity. Obesity 2007; 15(7): 1732-40.
26. Sramkova D, Krejbichova S, Vcelak J i sur. The UCP1 gene polymorphism A-3826G in relation to DM2 and body composition in Czech population. Exp Clin Endocrinol Diabetes 2007; 115(5):303-7.
27. Fairbrother UL, Tankó LB, Walley AJ, Christiansen C, Froguel P, Blakemore AI. Leptin receptor genotype at Gln223Arg is associated with body composition, BMD, and vertebral fracture in postmenopausal Danish women. J Bone Miner Res 2007;22(4):544-50.
28. Katsuda Y, Asano A, Murase Y i sur. Association of genetic variation of the adiponectin gene with body fat distribution and carotid atherosclerosis in Japanese obese subjects. J Atheroscler Thromb 2007; 14( 1): 19-26.
29. Zhang XL, Jiang X, Liu YP, Du HR, Zhu Q. Identification of Avai polymorphisms in the third intron of GH gene and their associations with abdominal fat in chickens. Poult Sci 2007;86(6): 1079-83.
30. Di Renzo L, Bigioni M, Bottini FG i sur. Normal Weight Obese syndrome: role of single nucleotide polymorphism of IL-15R alpha and MTHFR 677C-T genes in the relationship between body composition and resting metabolic rate. Eur Rev Med Pharmacol Sci 2006; 10 (5):235-45.
31. de Luis DA, Aller R, Izaola O, Gonzalez-Sagrado M, Conde R. Relation of Trp64Arg polymorphism of beta3-adrenoreceptor gene with cardiovascular risk factors in presurgical morbidly obese patients. Eur Rev Med Pharmacol Sei 2006;10(5):235-45.
32. Fang QC, Jia WP, Gao F i sur. Association of variants in APPL1 gene with body fat and its distribution in Chinese patients with type 2 diabetic mellitus. Zhonghua Yi Xue Za Zhi 2008;5;88(6):369-73.
33. Zillikens MC, Yazdanpanah M, Pardo LM i sur. Sex-specific genetic effects influence variation in body composition. Diabetologia 2008;51 (12):2233-41.
34. Horber FF, Ruber B, Thomi FA, Jensen EX, Haeger P. Effect of sex and age on bone mass, body composition, and fuel metabolism in humans. Nutrition 1997;13:424-534.
35. Olefsky JM, Jen P, Reaven GM, Alto P. Insulin binding to isolated human adipocytes. Diabetes 1974;23(7):565-71
36. Gavin JR 3rd, Saltman RJ, Tollefsen SE. Growth hormone receptors in isolated rat adipocytes. Endocrinology 1982; 110(2):637-43.
37. Spooner PM, Chernick SS, Garrison MM, Scow RO. Development of lipoprotein lipase activity and accumulation of triacylglycerol in differentiating 3T3-L1 adipocytes. Effects of prostaglandin F2alpha, 1- methyl-3-isobutylxanthine, prolactin, and insulin. J Biol Chem 1979;25; 254(4): 1305-11.
38. McAveney KM, Gimbte JM, Yu-Lee L. Prolactin receptor expression during adipocyte differentiation of bone marrow stroma. Endocrinology 1996;137(12):5723-6.
39. Kitabgi P, Rosselin G, Bataille D. Interactions of glucagon and related peptides with chicken adipose tissue. Horm Metab Res 1976;8(4): 266-70.
40. Tate RL, Holmes JM, Kohn LD, Winand RJ. Characteristics of a solubilized thyrotropin receptor from bovine thyroid plasma membranes. J Biol Chem 1975;25;250(16):6527-33.
41. Seres J, Bornstein SR, Seres P i sur. Corticotropin-releasing hormone system in human adipose tissue. J Clin Endocrinol Metab 2004;89(2): 965-70.
42. Attoub S, Levasseur S, Buyse M i sur. Physiological role of cholecysto-kinin B/gastrin receptor in leptin secretion. Endocrinology 1999; 140 (10):4406-10.
43. Valverde I, Mérida E, Delgado E, Trapote MA, Vtllanueva- Peñacarrillo ML. Presence and characterization of glucagon-like peptide-1(7-36) amide receptors in solubilized membranes of rat adipose tissue. Endocrinology 1993;132(l):75-9.
44. Kawamata Y, Habata Y, Fukusumi S i sur. Molecular properties of apelin: tissue distribution and receptor binding. Biochlm Biophys Acta 2001:1538:162-71.
45. Feldman D, Loose D. Glucocorticoid receptors in adipose tissue. Endocrinology 1977;100(2):398-405.
46. Kawada T, Kamei Y, Sugimoto E. The possibility of active form of vitamins A and D as suppressors on adipocyte development via ligand-de- pendent transcriptional regulators. Int J Obes Relat Metab Disord 1996; 20 Suppl 3:S52-7.
47. Ciaraldi TP, Marinetti GV. Hormone action at the membrane level. VIII. Adrenergic receptors in rat heart and adipocytes and their modulation by thyroxine. Biochim Biophys Acta 1978;541(3):334-46.
48. O'Brien SN, Welter BH, Mantzke KA, Price TM. Identification of progesterone receptor in human subcutaneous adipose tissue. J Clin Endocrinol Metab 1998;83:509-13.
49. Bai Y, Zhang S, Kim KS, Lee JK, Kim KH. Obese gene expression alters the ability of 30A5 preadipocytes to respond to lipogenic hormones. J Biol Chem 1996;271:13939-42.
50. Päth G, Bornstein SR, Gurniak M i sur. Human breast adipocytes express interleukin-6 (IL-6) and its receptor system: increased IL-6 production by beta-adrenergic activation and effects of IL-6 on adipocyte function. J Clin Endocrinol Metab 2001 ;86(5):2281-8.
51. Yamaguchi M, Murakami T, Tomimatsu T i sur. Autocrine inhibition of leptin production by tumor necrosis factor-alpha (TNF-alpha) through TNF-alpha type-I receptor in vitro. Biochem Biophys Res Commun 1998;244(l):30-4.
52. Fain JN and Garcia-Shinz JA. Adrenergic regulation of adipocyte metabolism. J. Lipid Res 1983;24:945-66.
53. Tavernier G, Barbe P, Galitzky J i sur Expression of beta3-adrenoceptors with low lipolytic action in human subcutaneous white adipocytes. J Lipid Res 1996;37(i):87-97.
54. Kuo LE, Kitlinska JB, Ttlan JU i sur. Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome. Nat Med 2007;13:803-11.
55. Zhang YY, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homolog. Nature 1994;372:425-32.
56. Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem Biophys Res Commun 1996;221(2):286-9.
57. Arita Y, Kihara S, Ouchi N i sur. Paradoxical decrease of an adipose- specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999;257(l):79-83.
58. Steppan CM, Brown EJ, Wright CM i sur. A family of tissue-specific resistin-like molecules. Proc Natl Acad Sci USA 2001;98(2):502-6.
59. Hida K, Wada J, Eguchi J i sur. Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity. Proc Natl Acad Sci USA 2005;102:10610-5.
60. Greenberg AS, Egan JJ, Wek SA. Garry NB, Blanchette-Mackie EJ, Londos C. Perilipin, a major hormonally regulated adipocyte-specific phosphoprotein associated with the periphery of lipid storage droplets. J Biol Chem 1991;266(17):11341-6.
61. Samad F, Yamamoto K, Pandey M, Loskutoff DJ. Elevated expression of transforming growth factor-b in adipose tissue from obese mice. Mol Med 1997;3:37-48.
62. Greenberg AS, Kimmel AR, Jablons D. Secretion of interleukin-6 by isolated rat adipocytes. Proceedings of the 71st Annual Meeting of the Endocrine Society 1989:267.
63. Vague P, Juhan-Vague I, Aillaud F i sur. Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects. Metabolism 1986;35(3):250-3.
64. Peake PW, O'Grady S, Pussell BA, Charlesworth JA. Detection and quantification of the control proteins of the alternative pathway of complement in 3T3-L1 adipocytes. Eur J Clin Invest 1997;27(11):922-7.
65. Lee DK, George SR, O 'Dowd B. Unraveling the roles of the apelin system: prospective therapeutic applications in heart failure and obesity. Trends Pharmacol Sci 2006;27:190-4.
66. Van Harmelen V, Ariapart P, Hoffstedt J, Lundkvist I, Bringman S, Amer P. Increased adipose angiotensinogen gene expression in human obesity. Obes Res 2000;8:337-41.
67. Fukuhara A, Matsuda M, Nishizawa M i sur. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 2005;307: 426-30.
68. Bozaoglu K, Bolton K, McMillan J i sur. Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology 2007; 148:4687-94.
69. Paglialunga S, Schrauwen P, Roy C i sur. Reduced adipose tissue triglyceride synthesis and increased muscle fatty acid oxidation in C5L2 knockout mice. J Endocrinol 2007;194(2):293-304.
70. Fain JN, Buehrer B, Bahouth SW, Tichansky DS, Madan AK. Comparison of messenger RNA distribution for 60 proteins in fat cells vs the nonfat cells of human omental adipose tissue. Metabolism 2008;57(7): 1005-15.
71. Skopkova M, Penesova A, Sell H i sur. Protein array reveals differentially expressed proteins in subcutaneous adipose tissue in obesity. Obesity 2007;15:2396-406.
72. Zechner R, Moser R, Newman TC, Fried SK, Breslow JL. Apolipoprotein E gene expression in mouse 3T3-L1 adipocytes and human adipose tissue and its regulation by differentiation and lipid content. J Biol Chem 1991;266( 16): 10583-8.
73. Taleb S, Lacasa D, Bastard JP i sur. Cathepsin S, a novel biomarker of adiposity: relevance to atherogenesis. FASEB J 2005;19(11):1540-2.
74. Bujalska IJ, Kumar S, Stewart PM. Does central obesity reflect «Cush- ing's disease of the Omentum»? Lancet 1997;349(9060):1210-3.
75. Cone RD. The central melanocortin system and energy homeostasis. Trends Endocrinol Metab 1999;10(6):211-6.
76. Mizuno TM and Mobbs CV. Hypothalamic agouti-related protein messenger ribonucleic acid is inhibited by leptin and stimulated by fasting. Endocrinology 1999;140(2):814-7.
77. Stanley BG, Kyrkouli SE, Lampert S, Leibowitz SF. Neuropeptide Y chronically injected into the hypothalamus: a powerful neurochemical inducer of hyperphagia and obesity. Peptides 1986;7(6):1189-92.
78. Weyer C, Funahashi T, Tanaka S i sur. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyper- insulinemia. J Clin Endocrinol Metab 2001;86(5): 1930-5.
79. Chitturi S, Abeygunasekera S, Farrell GC i sur. NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 2002;35(2):373-9.
80. Hida K, Wada J, Eguchi J i sur. Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity. Proc Natl Acad Sci USA 2005;102:10610-15.
81. Sheng CH, Di J, Jin Y i sur. Resistin is expressed in human hepatocytes and induces insulin resistance. Endocrine 2008;33:135-43.
82. Greenberg AS, Egan JJ, Wek SA, Garty NB, Blanchetle-Mackie EJ, Londos C. Perilipin, a major hormonally regulated adipocyte-specific phosphoprotein associated with the periphery of lipid storage droplets. J Biol Chem 1991 ;266:11341-6.
83. Joint World Health Organization/Food and Agriculture Organization Expert Consultation Diet, Nutrition and the Prevention of Chronic Diseases. WHO Technical Report Series no. 916. WHO: Geneva 2003.
84. Jensen TK, Andersson AM, Jorgensen N i sur. Body mass index in relation to semen quality and reproductive hormones among 1,558 Danish men. Fertil Steril 2004;82:863-70.
85. Cicuttini FM, Baker JR, Spector TD. The association of obesity with osteoarthritis of the hand and knee in women: a twin study. J Rheumatol 1996;23:1221.
86. Goulding A, Jones IE, Taylor RW, Williams SM, Manning PJ. Bone mineral density and body composition in boys with distal forearm fractures: a dual-energy x-ray absorptiometry study. J Pediatr 2001; 139(4): 509-15.
87. Flegal KM, Graubard BI, Williamson DF, Gail MH. Excess deaths associated with underweight, overweight, and obesity. JAMA 2005;293: 1861-67.
88. Olshansky SJ, Passaro DJ, Hershow Rcet AL. A potential decline in life expectancy in the United States in the 21st century. N Engl J Med 2005;352(11):1138-45.
89. Jelčić J, Koršić M, Hrvatsko društvo za debljinu. Hrvatski nacionalni konsenzus o dijagnostici i liječenju debljine. Liječ Vjesn 2007;129 (3-4):51-3.